CPT 93303 describes a complete transthoracic echocardiogram (TTE) performed for the evaluation of congenital cardiac anomalies. It is the congenital counterpart to the standard adult complete echo family, and its defining requirement is the indication: the study must be performed to evaluate known or suspected congenital heart disease — septal defects, transposition, tetralogy of Fallot, congenital valve malformations, and similar conditions. A key structural difference from the standard complete echo 93306 is that 93303 does not include Doppler in its descriptor: spectral Doppler (93320/93321) and color flow Doppler (93325) are reported separately when performed.
Report 93303 when a complete TTE is performed and the reason for the study is congenital heart disease — initial diagnostic evaluation of a suspected anomaly, or comprehensive assessment of a known anomaly, in pediatric or adult congenital patients. Add 93320 or 93321 for spectral Doppler and 93325 for color flow mapping when those techniques were used and documented, since the congenital echo codes do not bundle them. A complete congenital study is expected to image and describe the full segmental cardiac anatomy: situs, venous connections, atria, atrioventricular connections, ventricles, great vessels, and septa.
Do not report 93303 for a routine echo whose indication is acquired disease — heart failure, acquired valve disease, hypertension, murmur without suspected congenital anomaly — even in a pediatric patient; that is the 93306/93307/93308 family. Do not use it for a follow-up or limited congenital study, which is 93304. Do not report 93303 and a standard complete echo code for the same study. Patent foramen ovale evaluation and other borderline indications are payer-sensitive — many policies treat an isolated PFO study as a standard echo rather than a congenital one, so verify before defaulting to 93303. And do not bill the Doppler add-ons when Doppler was not actually performed and documented.
The report should state the congenital indication (suspected or confirmed diagnosis), document a segmental anatomic survey appropriate to a complete congenital study, and describe each Doppler technique billed with its findings. When 93320/93321 and 93325 accompany 93303, the interpretation must reflect spectral velocities/gradients and color flow findings respectively — Doppler line items without corresponding narrative are routine recoupment targets. The ICD-10 code on the claim should be the congenital anomaly (Q-chapter) or the appropriate suspected-condition coding per payer guidance, consistent with the report.
The code descriptors differ. 93306 explicitly includes spectral and color flow Doppler, so nothing is added. The congenital codes 93303 and 93304 describe the 2D anatomic study only, so 93320/93321 (spectral) and 93325 (color) are separately reportable when performed and documented.
No. The code is indication-driven, not age-driven. Adult congenital heart disease patients — a repaired tetralogy, an unrepaired septal defect — are appropriately studied under 93303/93304, and conversely a child with an acquired condition and no suspected anomaly gets a standard echo code.
Completeness. 93303 is the full initial or comprehensive segmental evaluation of congenital anatomy; 93304 is a follow-up or limited congenital study focused on a known anomaly or a specific question. Billing the complete code for a focused recheck is upcoding.
Generally yes, when the study was ordered and performed to evaluate a suspected congenital anomaly and the report reflects that indication — coding follows the reason for the test under signs/symptoms or suspected-condition rules. Payer policies vary on which ICD-10 codes support it, so match the payer’s coverage language.
Coding questions like this one are where revenue leaks start. See how Medtransic supports cardiology practices with certified billing and denial management: Cardiology Billing Services.